Evidence map›Paper›PMID 30892052›Full record

Observational studyAIDS research and human retroviruses2019

Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Marta E Bull, Jennifer L McKernan, Sheila Styrchak, Kelli Kraft, Jane Hitti, Susan E Cohn, Kenneth Tapia, Wenjie Deng, Sarah Holte, James I Mullins and 2 more

Open access · bronzeAbstract readComparative StudyObservational Study
In one paragraph

Observational study in AIDS research and human retroviruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Marta E Bull1 Department of Pediatrics, University of Washington, Seattle, Washington.
Jennifer L McKernan2 Center Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington.
Sheila Styrchak2 Center Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington.
Kelli Kraft2 Center Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington.
Jane Hitti3 Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington.
Susan E Cohn4 Department of Medicine, University of Rochester Medical Center, Rochester, New York.
Kenneth Tapia5 Department of Global Health and University of Washington, Seattle, Washington.
Wenjie Deng6 Department of Microbiology, University of Washington, Seattle, Washington.
Sarah Holte5 Department of Global Health and University of Washington, Seattle, Washington.
James I Mullins5 Department of Global Health and University of Washington, Seattle, Washington.
Robert W Coombs8 Department of Laboratory Medicine and Seattle, Washington.
Lisa M Frenkel1 Department of Pediatrics, University of Washington, Seattle, Washington.
University of Washington · USFred Hutch Cancer Center · USUniversity of Rochester Medical Center · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
HIV SHEDDING AND EVOLUTIONP01HD040540 · NICHD · UNIVERSITY OF WASHINGTON · PI COOMBS, ROBERT W. · 2001 to 2006
$7.5M
Mechanism/predictors of genital/rectal HIV shedding during ART w/plasma <50c/mLR01AI071212 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2006 to 2010
$2.4M
HIV-1 evolution in the female genital tract and trafficking to the bloodR01AI091550 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2011 to 2015
$1.9M
HIV-1 evolution in the female genital tract and trafficking to the bloodR56AI091550 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI FRENKEL, LISA M · 2010 to 2010
$606k
NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI071212NIAID NIH HHS R01 AI091550NIAID NIH HHS R56 AI091550NIAID NIH HHS T32 AI007140NICHD NIH HHS P01 HD040540
6 · The paper itself

Abstract

Identifying tissue sources of HIV that rebound following "failure" of antiretroviral therapy (ART) is critical to evaluating cure strategies. To assess the role of the uterine cervix and peripheral blood mononuclear cells (PBMC) as viral reservoirs, nearest-neighbor phylogenetic analyses compared genetic relatedness of tissue sequences during ART suppression to those detected in plasma at viral rebound. Blood and genital tract specimens from a natural history cohort of HIV-infected women were collected over 5 years. HIV DNA sequences extracted from PBMC and cervical biopsies during ART suppression and plasma RNA from rebound (defined as HIV RNA >3 log

Indexed as

PhylogenyAdultAnti-HIV AgentsBiopsyCervix UteriCohort StudiesDisease ReservoirsDNA, ViralDrug Resistance, ViralFemaleHIV-1HIV InfectionsHumansLeukocytes, MononuclearMiddle AgedMutationAnti-HIV AgentsDNA, ViralRNA, Viraldrug resistanceHIV-infected womenHIV reservoirsnearest-neighbor analysisphylogeneticsviral rebound

Identifiers

PMID30892052
PMCPMC6588103
OpenAlexW2922618739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.